A. Wilson

Clinical validation of hrHPV testing on vaginal and urine self-samples in primary cervical screening (cross-sectional results from the Papillomavirus Dumfries and Galloway—PaVDaG study)

H. Currie, M. Arbyn, K. Cuschieri, 2016, BMJ Open.

Self‐sampling as the principal modality for population based cervical screening: Five‐year follow‐up of the PaVDaG study

H. Currie, M. Arbyn, K. Cuschieri, 2021, International journal of cancer.

Defining Optimal Triage Strategies for hrHPV Screen–Positive Women—An Evaluation of HPV 16/18 Genotyping, Cytology, and p16/Ki-67 Cytoimmunochemistry

H. Currie, M. Arbyn, K. Cuschieri, 2017, Cancer Epidemiology, Biomarkers & Prevention.

The challenges of defining sample adequacy in an era of HPV based cervical screening.

K. Cuschieri, R. Bhatia, D. Ejegod, 2021, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Clinical performance of triage strategies for Hr-HPV positive women; a longitudinal evaluation of cytology, p16/Ki-67 Dual Stain cytology, and HPV16/18 genotyping.

H. Currie, M. Arbyn, K. Cuschieri, 2022, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Clinical performance of DNA and RNA based HPV tests for test of cure (TOC) post treatment for cervical intraepithelial neoplasia (CIN) - a retrospective study.

K. Cuschieri, R. Bhatia, Sharon Moncur, 2022, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.